Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin–piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial

Hellen C. Barsosio(Liverpool School of Tropical Medicine), Feiko O. ter Kuile(Liverpool School of Tropical Medicine), Miriam Taegtmeyer(Liverpool School of Tropical Medicine), Julie Gutman(Centers for Disease Control and Prevention), Victor Mwapasa(Kamuzu Central Hospital), James Dodd(Liverpool School of Tropical Medicine), Simon Kariuki(Kamuzu Central Hospital), Everlyne Delylah Ondieki(Kenya Medical Research Institute), Duolao Wang(Liverpool School of Tropical Medicine), Eric D Onyango(Kenya Medical Research Institute), Kamija S. Phiri(Museum of Malawi), Christentze Schmiegelow(Copenhagen University Hospital), Mwayiwawo Madanitsa(Malawi University of Science and Technology), Kephas Otieno(Kenya Medical Research Institute), Kenneth Maleta(University of Malawi)
The Lancet
January 1, 2024
Cited by 21


Related Papers